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Abstract
Background: Thiamine (vitamin B1) is an essential molecule for all life forms because thiamine diphosphate (ThDP) is an
indispensable cofactor for oxidative energy metabolism. The less abundant thiamine monophosphate (ThMP), thiamine
triphosphate (ThTP) and adenosine thiamine triphosphate (AThTP), present in many organisms, may have still unidentified
physiological functions. Diseases linked to thiamine deficiency (polyneuritis, Wernicke-Korsakoff syndrome) remain frequent
among alcohol abusers and other risk populations. This is the first comprehensive study on the distribution of thiamine
derivatives in human biopsies, body fluids and cell lines.
Methodology and Principal Findings: Thiamine derivatives were determined by HPLC. In human tissues, the total thiamine
content is lower than in other animal species. ThDP is the major thiamine compound and tissue levels decrease at high age.
In semen, ThDP content correlates with the concentration of spermatozoa but not with their motility. The proportion of
ThTP is higher in humans than in rodents, probably because of a lower 25-kDa ThTPase activity. The expression and activity
of this enzyme seems to correlate with the degree of cell differentiation. ThTP was present in nearly all brain and muscle
samples and in ,60% of other tissue samples, in particular fetal tissue and cultured cells. A low ([ThTP]+[ThMP])/
([Thiamine]+[ThMP]) ratio was found in cardiovascular tissues of patients with cardiac insufficiency. AThTP was detected
only sporadically in adult tissues but was found more consistently in fetal tissues and cell lines.
Conclusions and Significance: The high sensitivity of humans to thiamine deficiency is probably linked to low circulating
thiamine concentrations and low ThDP tissue contents. ThTP levels are relatively high in many human tissues, as a result of
low expression of the 25-kDa ThTPase. Another novel finding is the presence of ThTP and AThTP in poorly differentiated
fast-growing cells, suggesting a hitherto unsuspected link between these compounds and cell division or differentiation.
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Introduction
Thiamine is an essential molecule for all life forms. In animal
cells, thiamine is phosphorylated to ThDP by a specific enzyme,
thiamine pyro(di)phosphokinase (TPK, EC 2.7.6.2) (Fig. 1). As
ThDP is a cofactor for transketolase and pyruvate and 2-
oxoglutarate dehydrogenase complexes required for the oxidative
degradation of sugars and mitochondrial synthesis of ATP,
thiamine deficiency results in acute energy failure. In contrast to
microorganisms and plants, which are able to synthesize thiamine
de novo, animals require an exogenous source. Thiamine deficiency
in humans causes beriberi, a peripheral neuropathy and, mostly in
alcohol-misusing patients, Wernicke-Korsakoff syndrome [1,2].
Based on postmortem analysis, the prevalence of the latter is 1–2%
of the general population and 12–14% of the misusing population
[3], making it the third commonest cause of dementia, after
Alzheimer’s disease and vascular dementias [2]. Marginal
thiamine deficiency is probably more common than thought in
the elderly [4,5,6,7], in risk groups such as HIV-positive patients
[8,9,10], in patients with fast-growing hematologic malignant
tumors [11], after chronic liver failure [12] or following
gastrectomy [13]. Accidental thiamine deficiency was also recently
documented by the 2003 outbreak of encephalopathy in infants in
Israel, caused by a defective soy-based formula [14].
Thiamine deficiency or defects in thiamine metabolism were
also reported in other human pathologies. While one study
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13616reported normal total blood thiamine levels in patients with
Alzheimer’s dementia [15], others showed decreased levels in
plasma or erythrocytes [16,17]. ThDP levels are decreased in
postmortem brains of patients with Alzheimer’s disease [18,19]
and frontal lobe degeneration of the non-Alzheimer’s type [20].
Thiamine deficiency induces neuronal loss and cardiac failure.
The brain and the heart have an absolute requirement for
oxidative metabolism, and it is generally thought that the clinical
symptoms observed during thiamine deficiency result from
decreased tissular ThDP levels. However, in addition to the
well-known cofactor ThDP, other thiamine derivatives might also
play physiological roles [21] (Fig. 1). ThTP exists in animal tissues
in variable amounts [22]. ThTP is able to phosphorylate proteins
[23] and to activate large conductance anion channels in excised
patches of mouse neuroblastoma cells [24], but the physiological
significance of these results remains to be proven.
The mechanism of ThTP synthesis has long been controversial.
It now appears that there are at least two different mechanisms.
Kawasaki and coworkers showed that adenylate kinase 1 (AK1) is
able to synthesize ThTP according to the reaction ThDP + ADP
O ThTP + AMP [25,26]. This reaction may lead to a significant
synthesis of ThTP in skeletal muscle where this enzyme is
particularly abundant. We have shown that synthesis of ThTP is a
feature of all known AKs and that this reaction is always 10
6–10
7
times slower than ATP synthesis according to the reaction 2 ADP
O ATP + AMP [27]. In brain however, ThTP is synthesized in
mitochondria by a chemiosmotic mechanism, according to the
reaction ThDP + Pi O ThTP coupled to the respiratory chain
[28].
The enzymatic hydrolysis of ThTP has been reported in many
tissues. Mammalian tissues contain a membrane-associated
ThTPase [29,30,31] and a soluble cytosolic ThTPase [32]. The
membrane-associated ThTPase has not been characterized at the
molecular level. The soluble ThTPase (EC 3.6.1.28) is a 25-kDa
protein belonging to the CYTH superfamily [33] or triphosphate
tunnel metalloenzymes [34] and its three-dimensional structure is
known [35]. This ThTPase is expressed in virtually all mammalian
tissues [22,36,37] and appears to be mainly neuronal in brain [38].
Orthologs of the 25-kDa ThTPase are present in all animal
species, except possibly in birds [22].
Recently, we discovered the first thiamine adenine nucleotide,
adenosine thiamine triphosphate (AThTP), which accumulates in
E. coli during carbon starvation or collapse of the membrane H
+
gradient [39,40]. AThTP is also present in mammalian tissues. In
E. coli it can be synthesized by a ThDP adenylyl transferase,
present in the cytosol [41], according to the reaction ThDP + ADP
O AThTP + Pi. In carbon-starved E. coli, it rapidly disappears
after addition of glucose [39], suggesting the presence of an
AThTP-hydrolyzing enzyme. Furthermore, another adenine
thiamine nucleotide, adenosine thiamine diphosphate (AThDP),
exists, at least in mouse and quail liver [42], but we no information
concerning its synthesis or degradation.
Figure 1. Interconversion of thiamine derivatives in a model human cell. 1, cytosolic thiamine diphosphokinase (TPK); 2, cytosolic thiamine
diphosphatase (also hydrolyzes nucleoside diphosphates); 3, thiamine monophosphatase (hypothetical); 4, mitochondrial membrane-associated ThTP
synthase; 5, cytosolic adenylate kinase; 6, cytosolic 25-kDa ThTPase; 7, cytosolic ThDP adenylyl transferase; 8, AThTP hydrolase (hypothetical). The
mechanisms of AThDP synthesis and degradation are unknown. Dp, transmembrane H
+ gradient. Updated from [21].
doi:10.1371/journal.pone.0013616.g001
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derivatives and in particular ThTP and AThTP. There are only a
few studies on the distribution of these compounds in animal
tissues [22,42] and only two (from the same group) in humans
showing decreased ThTP levels in the postmortem brains of
patients with subacute necrotizing encephalomyelopathy (Leigh’s
disease) [43,44]. However, the compound measured in the latter
study may not have been authentic ThTP [45]. Indeed, ThTP
measurements were unreliable before the development of HPLC
techniques and we were unable to detect ThTP in human
postmortem brains [18,46], probably because of hydrolysis during
the postmortem delay.
Therefore, it is important to obtain information on the thiamine
status in humans, which can only be done reliably using fresh
tissue samples, especially in the case of ThTP and AThTP, which
are subject to rapid metabolic degradation. This is the first study
on the content of thiamine derivatives in various biopsied human
tissue samples and some human cultured cells. We also checked
the expression of the 25-kDa ThTPase by determination of its
enzyme activity, immunoblotting and RT-PCR. The results
obtained allow us to draw several interesting conclusions
concerning the distribution and the abundance of thiamine
compounds in humans.
Results
Biological stability and turnover of thiamine derivatives
in biological samples
A general problem associated with the detection of metabolites
in tissues is related to their biological stability. ATP, for instance
has a very high turnover with a half-life ,1 s. Thus, even the short
delay between the sacrifice of the animal and the freezing of the
target organ is sufficient for most of the ATP to be hydrolyzed
[47,48]. Reliable estimations of cellular ATP concentrations are
therefore difficult to obtain. The turnover of thiamine derivatives
is much slower, so that this issue is less important. We previously
showed that in cultured mouse neuro-2a cells, the turnover time of
ThDP is ,17 h at 37uC [49]. In a previous study on human brain
samples, we did not find a significant effect of the postmortem
delay (3–27 h, n=59) on ThDP levels [46], suggesting that reliable
estimations of ThDP content can be obtained on human
postmortem samples. However, it should be kept in mind that a
hydrolysis of only few percent of ThDP during the postmortem
delay would often go unnoticed but would lead to an important
increase in the comparatively minor ThMP, the product of
hydrolysis of ThDP. In the case of ThTP, the turnover time is
,1 h in neuro-2a cells which is slow enough for no significant
hydrolysis to occur during a normal sampling procedure.
However, a strong underestimation would be obtained for longer
postmortem delays. Indeed, in previous studies, we were unable to
detect any ThTP in human brain postmortem samples [18,46].
Therefore, a reliable estimation of ThTP content can only be
obtained from human biopsies. No data are available concerning
the biological stability of adenylated thiamine compounds in
animal tissues, but in carbon-starved E. coli, AThTP disappears
within a few minutes after addition of glucose [39].
Thiamine compounds in human blood and cerebrospinal
fluid (CSF)
Thiamine phosphate esters are hydrolyzed in the intestinal
lumen by various phosphatases (mainly the alkaline phosphatase
associated with brush-border membranes) and thiamine is taken
up through the intestinal mucosal membrane by a specific
saturable transporter (Km=4.4 mM) through an energy-dependent
process [50,51]. The vitamin is transported into erythrocytes by
another saturable, high-affinity transporter (Km=0.11 mM) and a
non-saturable component [52] that is probably not relevant at
physiological plasma concentrations. Indeed, the total (free +
protein-bound) thiamine concentration in human plasma is very
low (10–20 nM), while it reaches over 100 nM in rodent plasma,
which in addition also contains high amounts of ThMP [53].
Inside the erythrocytes, thiamine is pyrophosphorylated to ThDP
by TPK according to the reaction Thiamine + ATP O ThDP +
AMP. Though the equilibrium constant for this reaction is not in
favor of ThDP formation [54], the steady-state ThDP concentra-
tion in erythrocytes is much higher than that of free thiamine. It is
known that ThDP binds to transketolase with high affinity, but the
molar concentration of the enzyme is probably too low to explain
the shift of the equilibrium towards ThDP synthesis. Another
explanation is that the AMP formed is converted to ADP by AK1,
which is abundant in human red blood cells [54]. This would
explain that the free ThDP can accumulate to some extent in the
cytoplasm and is trapped in the cell (as it cannot cross the
membrane). In human erythrocytes, up to 10% of the free ThDP
can be converted to ThTP, a reaction catalyzed (albeit very slowly)
by AK1 according to the reaction ThDP + ADP O ThTP + AMP
[54].
Many different methods for the determination of thiamine
derivatives in human whole blood, erythrocytes, serum or plasma
have been described and it is not the aim of the present work to
review all these data, which has been done previously [55,56].
Here, we essentially wanted to investigate the possible presence of
ThTP and AThTP in these fluids.
In agreement with previous results [57,58,59,60], whole human
blood contained thiamine, ThMP, and ThDP (Table 1). ThTP
accounted for nearly 10% of total thiamine, which is more than in
most human cells, while ThMP and free thiamine were less
abundant. We detected no significant amounts of AThDP or
AThTP in human blood. Plasma contained low amounts of
thiamine and ThMP, but neither ThDP nor ThTP. Similar
concentrations of free thiamine (10–20 nmol/L) in human plasma
or serum have been reported by us [61] and other workers
[59,61,62]. In human blood, total thiamine concentrations are
nearly an order of magnitude lower than in blood of rodents and
other animals [53,63].
In human CSF, we only found thiamine and ThMP, in
agreement with Rindi and coworkers [64]. ThMP is probably
transported through the choroid plexus by the reduced folate
transporter (SLC19A1), that is very abundant in the apical (CSF)
side of the choroid plexus [65] and able to transport ThMP (but
not thiamine) in addition to reduced folate [66].
Table 1. Distribution of thiamine derivatives in human whole
blood, plasma and CSF.
(nmol/L) Thiamine ThMP ThDP ThTP AThTP
Whole blood (7) 4631 0 64 138633 1364n . d .
Plasma (3) 11635 62 n . d .n . d .n . d .
CSF (3) 19653 0 65 n . d .n . d .n . d .
The blood was from 7 healthy volunteers aged from 25 to 49 years. Aliquots of
three samples were centrifuged to obtain a plasma preparation. CSF was from
three patients with no known neurological disorder. The results are expressed
as means 6 SD. The numbers in parentheses indicate the number of patients.
n. d., not detected.
doi:10.1371/journal.pone.0013616.t001
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cardiovascular system
We determined thiamine compounds in biopsies from various
human tissues, including colon, lung, thymus, skin, skeletal muscle
and various elements of the cardiovascular system from 33 patients
(Table 2). In some cases, several kinds of anatomically different
samples from similar tissues (veins, arteries or valves) were pooled
for statistical reasons, as there were no obvious differences between
them. The 33 patients were aged between 37 and 82 years. At first,
it appeared that the content of thiamine compounds was highly
variable from one patient to another, as evidenced by the high
coefficient of variation (Cv), often .0.7. ThMP and ThDP were
found in all patients. Free thiamine and ThTP were found in only
half of the samples. Skeletal muscle always contained measurable
amounts of ThTP, except for one patient aged 82 with also very
low ThDP levels. The presence of ThTP (mostly cytosolic) in
skeletal muscle is probably related to the high content of AK1. As
mentioned above, erythrocytes contain relatively high amounts of
ThTP for probably the same reason.
In most tissues investigated, the cofactor ThDP was the most
abundant thiamine compound, with the highest content in heart
auricles and skin, followed by kidney, lung, colon, adipose tissue,
skeletal muscle and vascular samples. We tested whether there was
a correlation between the age of the patients and the content of
thiamine derivatives. Indeed, using linear regression analysis, we
found a significant negative correlation between age and ThDP
levels. The ThDP content decreased with the age of the patients in
skeletal muscle [F(1,9)=6.701, p=0.0293, R
2=0.43] and lung
[F(1,5)=14,730, p=0,0121, R
2=0.75], for which we had the
most complete series of samples. No significant correlation was
found for ThTP [F(1,8)=0.6348, p=0.45, R
2=0.074] or ThMP
[F(1,9)=1.547, p=0.25, R
2=0.15] in skeletal muscle, but a
significant negative correlation between ThMP and age
[F(1,5)=11.853, p=0.0184, R
2=0.70] was observed in lung. A
significant negative correlation was also found between total
thiamine content and age in skeletal muscle [F(1,9)=9.408,
p=0.0134, R
2=0.51] and lung [F(1,5)=17.6073, p=0.0085,
R
2=0.78]. In a previous study limited to human postmortem
brains, we already observed a tendency for decreased ThDP and
total thiamine levels with age, and in particular in the highest age
group ($77 years) [46], though TPK activities were normal.
In veins and arteries, ThDP levels were relatively low, while
ThTP levels were proportionally high, accounting in two patients
for about 15%–16% of total thiamine. This seems to be a
characteristic of human tissues, as in aorta and vena cava from
rats, ThTP represented only respectively 0.6% (0.27 pmol/mg of
protein, n=3) and 0.3% (0.23 pmol/mg of protein, n=3) of total
thiamine (not shown).
It is interesting to note that, in some patients, ThTP was below
detection limit in all tissues, except skeletal muscle. In these
patients, free thiamine was present, sometimes in high amounts.
Therefore, we separated the patients in two categories: those with
a ‘‘positive’’ thiamine phosphorylation shift (toward ThTP) and
those with a ‘‘negative’’ thiamine phosphorylation shift (toward
thiamine). We calculated the ([ThTP] + [ThMP])/([Thiamine] +
[ThMP]) ratio for each patient by taking the mean of all tissues
from the same patient. We have previously shown that there are at
least two ThDP pools, a larger low-turnover cofactor pool and a
smaller high-turnover pool, precursor of ThTP and ThMP
[49,67]. Therefore, as we do not know the size of the free high-
turnover ThDP pool, this derivative was omitted from the
equation. We called this ratio the ‘‘thiamine phosphorylation
ratio’’ (TPR). 20 patients (61%) had a TPR $1, while 11 (39%)
had a TPR ,1. We did not find a significant correlation between
TPR and total thiamine content in our samples [F(1,28)=0.0059,
p=0.94, R
2 ,0.0001]. Also, the TPR did not correlate with the
age of the patients [F(1,28)=0,09719, p=0,7575, R
2=0,003459].
From the retrospective analysis of the clinical charts, we did not
find arguments for a relation between underlying neoplastic
disease and a low TPR. However, among the patients with low
TPR all but one had a significant degree of heart failure based on
clinical assessment (New York Heart Association Functional
Table 2. Distribution of thiamine derivatives in human biopsies.
(pmol/mg of protein) Thiamine ThMP ThDP ThTP AThTP
Colon (2) 0.0760.06 2.162.4 30622 0.360.2 n. d.
Lung (7) 2.2.61.1 2.060.9 30612 0.49 [1] 0.43 [1]
Kidney (1) 3.5 80 33 0.19 n. d.
Thymus (6) 0.2360.16 [2] 1.160.4 7.160.9 1.1 [1] 0.81 [1]
Skin (3) 2.160.6 3.660.8 47612 0.4460.09 0.1360.05 [2]
Adipose tissue (11) 364 [4] 3632 7 623 262 [5] 0.860.4 [2]
Skeletal muscle (11) 0.660.7 [7] 0.760.4 17612 161 [10]
4 1.561.4 [2]
Heart auricle (5) 0.63 [1] 1.460.7 66641 0.460.5 [4] n. d.
Pericardium (6) 1.360.6 [3] 0.860.5 4.862.3 0.25 [1] n. d.
Veins
1 (10) 1.461.0 [6] 1.761.4 9663 64 [6] 1.461.4 [3]
Arteries
2 (6) 1.060.8 [4] 2.462.0 1067 0.860.3 [4] 769 [2]
Valves
3 (5) 2.663.6 [2] 0.960.5 4.762.2 1.861.5 [2] 1.361.2 [2]
Among the 33 patients, 29 were hospitalized because of cardiovascular problems. The results are expressed as means 6 SD. The numbers in parentheses indicate the
number of patients. The numbers in brackets indicate the number of samples in which the compound was observed, if different from the number of patients.
n.d., not detected.
1great sapheneous vein, mammary vein,
2mammary artery, radial artery, coronary artery.
3mitral valve, aortic valve.
4One patient, of 82 years, had no measurable ThTP in the skeletal muscle sample. This sample also had a low ThDP content (5 pmol/mg of protein).
doi:10.1371/journal.pone.0013616.t002
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syndrome is characterized by a diffuse neuro-hormonal activation
and metabolic shifts [68,69]. Therefore, this possible and plausible
correlation warrants further study and is currently under
prospective investigation in our institution.
As for AThTP, it was detected in only 15 samples from 10
patients (out of 33). AThTP was present in 35% of the samples
containing AThTP, but in only 3% of the samples devoid of
ThTP. This difference is highly significant (p=0.0009), suggesting
that the appearance of AThTP is linked to the presence of ThTP.
This is in contrast to what is observed in bacteria where ThTP and
AThTP do not generally accumulate together [39].
Thiamine derivatives in normal and ischemic human liver
We thought that ischemia might affect the distribution of
thiamine derivatives in liver tissue. Indeed, it is known that
thiamine protects against hypoxia-induced cell death in cultured
neonatal rat cardiomyocytes [70] and accelerates the healing of
diabetic ischemic limbs in mice [71]. This may be one of the
reasons why thiamine supplementation improves renal transplan-
tation outcome in humans [72]. However, we did not observe any
effect of ischemia on the levels of thiamine compounds in liver
(Table 3). Neither AThDP nor AThTP were found in human
liver, in contrast to mouse [42] or rat [39] liver. Human liver
contained significant amounts of ThTP (.1% of total thiamine),
and ,73% of ThTP was found in the supernatant after
centrifugation of the liver homogenate at 100 0006g. This may
be a difference with brain or cardiac tissue, where a large part of
ThTP is mitochondrial [28] and might therefore be more sensitive
to ischemia.
Thiamine compounds and 25-kDa ThTPase in
gynecological and embryonic tissues
As the fetus continuously grows, it acts as a thiamine sink,
explaining a 10 to 1 ratio of the thiamine concentrations in the
maternal versus venous cord plasma [73]. ThDP was the major
compound observed in human adult gynecological specimen and
in embryonic tissues (Table 4). A high amount of ThMP was also
found in several samples such as fibroma, ligament, serosa and
endometrium. It could be argued that this high proportion of
ThMP is the result of a hydrolysis of ThDP after the sample was
taken. However, we took care, first, to freeze the samples as
quickly as possible and the delay was never longer than a few
minutes (generally less than 2 minutes). Secondly, we previously
showed that, at least in the human brain, a postmortem delay of
several hours does not significantly change the relative thiamine,
ThMP or ThDP levels [18,46], suggesting that ThDP hydrolysis is
slow. Indeed, though some nucleoside diphosphatases are able to
hydrolyze ThDP [74,75], no specific thiamine diphosphatase has
yet been characterized. This does however not exclude that in
some tissues unspecific phosphatases might be responsible for a
rapid hydrolysis of ThDP. This is in contrast to ThTP, which
rapidly disappears during the postmortem delay, probably because
Table 3. Distribution of thiamine derivatives in normal and
ischemic human liver.
(pmol/mg of
protein) Thiamine ThMP ThDP ThTP AThTP
Normal (3) 0.2660.07 3624 5 629 1.761.8
a n. d.
Ischemic (3) 0.960.8 4634 8 615 0.260.2 n. d.
The results are expressed as means 6 SD. The numbers in parentheses indicate
the number of patients.
aOne patient had a very high ThTP content (3.8 pmol/mg, or 12% of total
thiamine).
n.d., not detected.
doi:10.1371/journal.pone.0013616.t003
Table 4. Distribution of thiamine derivatives in human embryonic tissues and adult gynecological specimen.
(pmol/mg of protein) Thiamine ThMP ThDP ThTP AThTP
Placenta (4) 1.760.5 0.960.8 15610 0.1260.07 0.960.6
Umbilical cord (2) 3.160.9 0.860.4 564 0.13 [1] 0.17 [1]
Trophoblast (7) 1.661.2 12617 26610 0.260.1 0.0860.06 [4]
Fetus (7) 6654 623 3 67 0.360.2 0.0960.05 [4]
Ovary (4) 0.360.3 5683 9 624 0.06 [1] 0.08 [1]
Serosa (uterus) (1) n. d. 46 21 n. d. n. d.
Vagina (1) 0.05 2.8 7.1 n. d. n. d.
Ectocervix (1) 1.6 2.0 9.1 n. d. n. d.
Endocervix (2) 0.560.2 2.761.6 46653 n. d. n. d.
Uterus (myometrium (6) 0.960.6 1.960.4 1764n . d . n . d .
Endometrium (3) 0.160.1 18617 1365n . d . n . d .
Fallopian tube (3) 0.860.5 1.760.4 36610 0.1560.1 [2] 0.1060.02 [2]
Infundibulum (2) 0.460.2 16622 2165n . d . n . d .
Round ligament (1) 0.09 74 21 n. d. n. d.
Peritoneum (1) 0.38 1.8 15 n. d. n. d.
Fibroma (uterus) (8) 262 [6] 12618 1767n . d . n . d .
The embryonic tissues come from voluntary interruption of pregnancy, while the adult tissues were taken from patients suffering from menorrhagy or dysmenorrhea.
The 27 patients were aged 18–77 years. The results are expressed as means 6 SD. The numbers in parentheses indicate the number of patients. The numbers in
brackets indicates the number of samples in which the compound was observed, if different from the number of patients.
n.d., not detected
doi:10.1371/journal.pone.0013616.t004
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phosphohydrolases [28].
ThTP was consistently found in fetal tissue and in particular
placenta, but only sporadically in adult tissues. This also holds,
though to a lesser extent, for AThTP. Indeed, among the samples
containing ThTP, 53% also contained AThTP, while AThTP was
only found in 10% of the samples devoid of ThTP (p=0.0006).
Therefore, as for the samples of Table 2, these data suggest that
the presence of AThTP is linked to the presence of ThTP. AThDP
was only rarely detected.
We compared the activities of the 25-kDa ThTPase in these
tissues (Table 5). The enzyme activity was low in fetus and
trophoblast, but it was substantially higher in endometrium and
uterus. A high activity was also previously observed in mouse
uterus [37] and a high expression of the ThTPase mRNA in
human uterus [36], in agreement with our present data. While
significant amounts of ThTP are observed in fetal tissues, this
compound is below detection limit in adult gynecological tissues
(Table 4). These results suggest that 25-kDa ThTPase is important
for the regulation of cellular ThTP levels in vivo, which has never
been demonstrated before.
Thiamine compounds in human semen
Spermatogenesis requires thiamine, as evidenced in transgenic
mice lacking the high-affinity thiamine carrier ThTR1 [76]. Null
males have hypoplastic testes secondary to apoptosis of pachytene
stage spermatocytes, but to our knowledge, no determination of
thiamine compounds in human semen has ever been published.
Our results show that whole semen contained thiamine, ThMP
and ThDP in variable amounts (Table 6). No adenylated thiamine
derivatives were found. We observed a positive correlation
[F(1,10)=21.36, p,0.0009, R
2=0.68] between ThDP content
and number of spermatozoa per mL of semen, which varied from
1.8.10
6 to 135.10
6 (azoospermic semen samples were not included
in this correlation). No significant correlations were found for
thiamine or ThMP. These results suggest that ThDP is mainly
localized within spermatozoa. This conclusion is also supported by
the observation that ThDP concentration was low in seminal fluid
prepared from whole semen. Several studies suggested a
relationship between sperm motility and oxidative phosphoryla-
tion [77], while other studies suggested that, at least in human
sperm cells, glycolysis is a primary energy source for motility [78].
We did not find a significant correlation [F(1,10)=3.890,
p=0.0768, R
2=0.28]) between ThDP content of spermatozoa
and the percentage of motility (% of spermatozoa with a
progressive motility $25 mm/sec at 37uCo r$20 mm/sec at
20uC), though a tendency seemed to exist. ThDP is a cofactor for
transketolase in the pentose phosphate shunt and it was shown that
experimental inhibition of the pentose phosphate pathway
impaired progressive motility of human spermatozoa [79]. It is
therefore plausible that the tendency of highly motile spermatozoa
to have a high ThDP content is indicative of the functioning of the
pentose phosphate pathway rather than of mitochondrial metab-
olism. Indeed, the pentose phosphate pathway is the main source
for NADPH, required for the reduction of glutathione by
glutathione reductase. Reduced glutathione is essential in
antioxidant defense for spermatozoa, which have limited antiox-
idant capacity because of their small cytoplasmic volume. ThDP, a
cofactor for transketolase, is essential for maintaining the flux
through the oxidative part of the pathway, when the requirement
or NADPH is high.
In some samples, a peak eluting close to ThTP was observed. It
did however not disappear upon treatment with ThTPase,
suggesting that it was not ThTP. Testis and prostate are among
the tissues that display the highest expression of 25-kDa ThTPase
mRNA [36,37]. In rat testis, 25-kDa ThTPase mRNA is highly
expressed in cells close to the basal lamina of the seminiferous
tubules. No signal was observed in mature spermatozoa, probably
because the cytoplasmic volume is extremely reduced.
Thiamine derivatives in the brain
We determined thiamine derivatives in pig, rat, quail and
human brain samples (Table 7). ThDP and thus total thiamine
levels were much lower in human brain than in rat, quail or pig
brain. The Cv for ThDP was 5/21=0.24, which was the same as
the Cv for postmortem brains previously obtained [46] and lower
than for many other tissues in this study, such as skeletal muscle
(0.71, Table 2), heart auricle (0.67, Table 2) or liver (0.64, Table 3).
In a previous study, we checked thiamine derivatives in the brain
of the baboon Papio papio [48] and the mean ThDP content was
,5 nmol/g of fresh weight. Considering that proteins account for
about 13% of fresh weight, this corresponds to 38 pmol/mg of
protein, a value twice higher than for human brain, but still much
lower than for rodent brain.
Table 6. Thiamine compounds in human semen.
Thiamine ThMP ThDP
(nmol/L) (nmol/L) (nmol/L)
Whole
sperm (12)
Controls 30616 25614 45622
Azoospermia
a (1) 60 20.4 6
Azoospermia
b (1) 16 20 21
Azoospermia
c (1) 34 9 ,2
Repermeabilization
d (1) 115 2.1 45
Seminal
fluids (9)
Controls 30622 24619 1466
Azoospermia (2) 54641 12681 3 69
The samples were from 12 healthy men aged from 25 to 42 years. The
abstinence time was 361 days and the delay between ejaculation and freezing
of the samples was 60630 min. Seminal fluids were obtained by centrifugation
(5006g, 10 min). The results are expressed as mean 6 SD. The numbers in
parentheses indicate the number of patients. We did not find any significant
effects of the delay before freezing on the contents of thiamine derivatives.
aAzoospermia as a result of intake of anabolic steroids.
bAzoospermia as a result of chemotherapy following testicular cancer.
cAzoospermia as a result of vasectomy.
dRepermeabilization after vasectomy (86.10
6 spermatozoa/mL).
doi:10.1371/journal.pone.0013616.t006
Table 5. Soluble 25-kDa ThTPase activities in human tissues.
ThTPase activity (nmol.mg
21.min
21)
Trophoblast 0.0360.01
a
Fetus 0.0960.01
b
Brain (temporal cortex) 0.1060.04
c
Endometrium 0.1860.02
Uterus (myometrium) 0.2660.01
a, significantly lower than fetus, brain (p,0.05); endometrium, uterus (p,0.001).
b, significantly lower than endometrium (p,0.01) and uterus (p,0.001).
c, significantly lower than endometrium (p,0.01) and uterus (p,0.001).
Mean 6 SD, n=3.
doi:10.1371/journal.pone.0013616.t005
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reveal important regional differences in the distribution of
thiamine derivatives, though ThDP levels were somewhat higher
than average in mammillary bodies and lower in hippocampus
[46].
In human brain, ThTP levels were relatively high, accounting
for ,1% of total thiamine. Even higher ThTP levels were found in
quail and pig brain in agreement with previous results [80]. This is
mainly due to the presence of very low catalytic activity of the 25-
kDa ThTPase in pigs [81], while birds probably have no 25-kDa
ThTPase [22]. These results clearly suggest an inverse correlation
between brain ThTP content and soluble 25-kDa ThTPase
activity.
In rat brain, we compared brainstem, right and left cortical
hemispheres as well as cerebellum. There were no important
differences between the regions, except that ThTP levels were
significantly higher in the brainstem than in the cerebellum
(p,0.05). AThTP levels were low and highly variable. While
AThTP was found in rat brain, it was always absent in pig, quail
and human brain.
ThTP and AThTP in cultured human and rodent cell lines
Thiamine derivatives were determined in cultured cells from
human and rodent origin. We tested human neuroblastoma cells
(SK-N-BE), human glioblastoma cells (LN-18), mouse myoblasts
(C2C12), mouse fibroblasts (3T3), mouse neuroblastoma (neuro-
2a) and rat phaeochromocytoma (PC-12) cells (Table 8).
Significant amounts of ThTP were detected in all cell lines
except 3T3. Surprisingly, AThTP was more abundant than ThTP
in all cell lines except the mouse neuroblastoma neuro-2a cells.
The highest amount of AThTP was found in human glioblastoma
LN-18 cells. It should be reminded that AThTP was also
consistently detected in tissues that proliferate quickly (placenta,
trophoblast and fetus at an early state of development, Table 4).
Therefore the presence of AThTP, ThTP and a low 25-kDa
ThTPase activity may be features of undifferentiated fast-growing
cells.
Expression of 25-kDa ThTPase in brain and cell lines from
different species
As various phosphatases are able to hydrolyze ThTP, we made
several tests to make sure that ThTP hydrolysis observed in
extracts from cultured cells is catalyzed by 25-kDa ThTPase. We
checked that the pH optimum is around 8.5, characteristic of 25-
kDa ThTPase, and that the enzyme activity was observed in the
presence of Mg
2+ and not Ca
2+ [82]. The substrate concentration
used was 10 mM as, at such low concentrations, ThTP hydrolysis
by alkaline phosphatase for instance is negligible.
25-kDa ThTPase activity is significant in human brain, but ,20
times lower than in mouse brain (Fig. 2). This might explain the
relatively high proportion of ThTP compared to total thiamine in
human brain, compared with other species such as rodents.
Furthermore, 25-kDa ThTPase mRNA expression was uniformly
low in human brain with a somewhat higher expression in the
parietal and occipital lobes and a lower expression in the
cerebellum [36]. This is also true in mouse brain: both mRNA
expression and enzyme activities were somewhat lower in the
cerebral compared to the cerebellar cortex [37].
While a significant ThTPase activity could be measured in
mouse C2C12 and 3T3 cells, no activity was detected in human
SK-N-BE and LN-18 cells. We were unable to measure any
significant ThTPase activity in human cell lines. Though the Km
and Vmax for purified recombinant 25-kDa ThTPase are
respectively 175621 mM and 5.960.2 mmol s
21 mg
21 for the
human [82] and a little less than 100 mM and ,10–12 mmol s
21
mg
21 for the mouse enzyme [35], these differences do not explain
a specific activity in human brain less than 5% of that of mouse
brain. Indeed, at the 10 mM substrate concentration used in this
study, both enzymes have approximately the same specific activity.
Therefore, our data suggest a lower expression of the enzyme in
human, compared to mouse tissues. The expression was even
lower in cultured cells. This result is surprising as, by RT-PCR,
mRNA could be detected in all cell lines (Fig. 3).
Table 8. ThTP and AThTP in cultured cell lines.
(pmol/mg of
protein) ThTP AThTP
Mouse C2C12 0.2960.02 4.760.2
3T3 n. d. 2.560.4
Neuro-2a 0.960.4 0.0760.09
Rat PC-12 2.260.4 2.660.5
Human SK-N-BE 0.860.3 4.061.0
LN-18 0.760.1 2061
Mean 6 SD, n=3.
n. d., not detected.
doi:10.1371/journal.pone.0013616.t008
Table 7. Thiamine derivatives in brain samples.
(pmol/mg of protein) Thiamine ThMP ThDP ThTP AThTP
Pig Cerebral cortex (3) 1361 5.561.1 6661 1.560.4 n. d.
Quail Forebrain (3) 0.960.1 2.060.4 116621 2.860.6 n. d.
Rat Brainstem (5) 4.360.4 1062 115612 0.5060.12* 0.260.3
Right hemisphere (5) 4.460.6 961 153665 0.3560.09 0.160.2
Left hemisphere (5) 5.261.6 962 14868 0.3660.08 0.260.3
Cerebellum (5) 4.462.6 1462 168654 0.3160.05 0.160.2
Human Cerebral cortex
a (5) 0.260.3 3.562.6 2165 0.460.3 n. d.
aPeritumoral cerebral tissue, from patients with temporal lobe glioblastoma.
*p,0.05, compared with cerebellum.
The results are expressed as mean 6 SD. n.d., not detected.
doi:10.1371/journal.pone.0013616.t007
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the presence of a catalytically inactive form of the enzyme, we
performed Western blots on human tissues and on SK-N-BE and
LN-18 cells using commercial mouse monoclonal and polyclonal
antibodies directed against recombinant hThTPase. The monoclonal
antibody proved to be useless (see File S1). The polyclonal antibody
recognizedabandofthecorrectmolecularmassinendometriumand
uterus (Fig. 4), but no or possibly only very faint bands of the correct
molecular mass were detected in cultured human cells and
trophoblast. Purified recombinant 25-kDa human ThTPase [22]
was used as a positive control. These results show that, in agreement
with enzyme activity determinations, the 25-kDa soluble ThTPase
protein is mainly expressed in adult tissues. The presence of mRNA
was shown by RT-PCR analysis and therefore we propose that the
expression of the protein may be controlled at the level of translation
or by posttranslational modification. A similar conclusion has been
reached previously for mouse tissues and it was proposed that the
highly conserved 200-nucleotide 39-untranslated mRNA region
might be involved in the control of translation [37].
Discussion
This is the first comprehensive study on the distribution of all
known thiamine derivatives in biopsied human tissues and body
fluids. Though at least one study reported the distribution of
thiamine derivatives in human brain [46], it was a postmortem
study and it is known that some derivatives, in particular ThTP,
are hydrolyzed during the postmortem delay. No data were
available concerning the existence of ThTP and AThTP in human
tissues or cultured cells. From the present study we can draw
several general conclusions.
Human tissue ThDP levels are relatively low
Tissue levels of thiamine derivatives have a high inter-patient
variability in peripheral tissues. This is not observed in laboratory
Figure 2. 25-kDa ThTPase activities in the brain and cultured cell lines from humans and mice. (A) ThTPase specific activities measured at
pH 8.5, at 37uC and at a Mg
2+ concentration of 10 mM (means 6 SD, n=3) in mouse and human brain and cell lines. (B) pH profile of ThTPase activity
from various sources (means 6 SD, n=2). The buffers (50 mM final concentration) used were: Pipes (pH 6.5), Mops (pH 7.1), Hepes (pH 7.5), Taps
(pH 8.0), Bis-Tris-Propane (pH 8.5) and Ches (pH 9.1 and 9.5).
doi:10.1371/journal.pone.0013616.g002
Figure 3. Amplification of 25-kDa ThTPase mRNA in different cell
lines by RT-PCR. (SL, standard ladder; S, SN-K-BE; C, C2C12; L, LN-18).
doi:10.1371/journal.pone.0013616.g003
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nutrition, disease, age, alcohol consumption or drug treatment.
Furthermore, it must be emphasized that the biopsies were from
patients suffering from various clinical conditions, which might be
an additional factor impacting on variability. However, human
brain ThDP content, while low, was less variable than in peripheral
tissues, suggesting a tight regulation of thiamine homeostasis in
brain. This is further emphasized by previous findings that in the
thiamine-deficient rat, the rate of disappearance of thiamine is
much slower in the brain than in the liver [83,84].
Total thiamine levels (essentially ThDP, which accounts for
most of total thiamine) are much lower in humans than in rodents.
Furthermore, human brain total thiamine levels are also much
lower than in other animals (Table 7), which could explain the
particular sensitivity of the human nervous system to thiamine
deficiency. As thiamine levels are already low in human whole
blood and plasma, it is possible that intestinal transport of the
vitamin is not very efficient in humans. In rodents, the liver
contains the highest amount of total thiamine per mg of protein,
essentially in the form of ThDP. This, as well as its size, makes it a
thiamine store, as recently suggested [85]. This is also underscored
by the observation that end-stage liver failure results in thiamine
deficiency by depletion of thiamine stores [12]. However, in
human liver, total thiamine levels are at least an order of
magnitude lower than in rodent liver. Therefore, there is only a
very limited storage capacity for thiamine in the human body.
This might explain that marginal thiamine deficiency is relatively
common in humans. It should be reminded for instance that in the
Japanese Navy in the years 1878–1882, each year a third of all
enlisted men became sick with beriberi [86]. In rats, overt
symptoms of thiamine deficiency occur only after brain thiamine
levels drop below 20% of controls, indicating a substantial brain
reserve of the vitamin [87]. This threshold value is slightly above
the human controls. In one of the rare studies of experimental
thiamine depletion in humans, the subjects developed the first
clinical symptoms after only two weeks on a diet containing
0.15 mg of thiamine per day [88]. In rodents, complete absence of
thiamine in the diet leads to deficiency symptoms only after 4.5 to
9 weeks [87,89,90] and generally, the antimetabolite pyrithiamine
is administered to accelerate the development of deficiency [91].
These differences between rodents and humans could also, at least
in part, be explained by differences in intestinal flora and the
presence in the rodent caecum of bacteria able to synthesize
thiamine de novo. The fact that thiamine levels might be close to
deficiency threshold in humans is further emphasized by the
observation that thiamine supplementation can lead to increased
well-being [4,92]. Our results show that, at least in muscle and
lung, there is a negative correlation between age and ThDP and
total thiamine content. We have previously observed that, in
postmortem human brain, ThDP (and total thiamine) levels
tended to be highest in very young individuals and decreased in
the highest age group (.77 years) [46]. Such a decrease would be
in agreement with a decreased thiamine status in elderly people
[4,93,94], probably as a result of decreased intestinal absorption
[95]. Finally, there appear to be many tissue or cell-specific
differences in the metabolism of thiamine and thiamine phosphate
derivatives, which could explain differences in sensitivity to
thiamine deficiency, as already suggested previously for cultured
human cells [96].
ThTP is relatively abundant in human tissues
ThTP is relatively abundant in some tissues, sometimes
reaching over 10% of total thiamine (Table 2). This high ThTP
content is probably linked to a relatively low specific activity of 25-
kDa ThTPase (see below). ThTP is always observed in brain and
skeletal muscle. It has been proposed that, in skeletal muscle,
ThTP is synthesized by AK1 [25,26], while in brain it is
synthesized in mitochondria by a chemiosmotic mechanism [28].
In the latter case, ThTP can be released from the mitochondria
and may be subsequently hydrolyzed by the cytosolic ThTPase.
As for other thiamine derivatives, inter-patient variability was
very high for ThTP. In some patients, ThTP was undetectable
while in other patients the same tissue contained a relatively high
proportion of ThTP. An inverse relationship was observed for
thiamine. Therefore, we defined a new parameter, the TPR,
reflecting the degree of phosphorylation of thiamine derivatives.
This parameter, at least in cardiovascular tissues, seems to be a
characteristic of a given patient, at least at a precise moment of his
or her life. This parameter tended to be lower in patients suffering
from cardiac insufficiency. It is well known that severe thiamine
deficiency is often accompanied by acute congestive heart failure.
A recent study showed that thiamine deficiency-induced heart
failure in the rat involves oxidative stress induced apoptosis [97].
Furthermore, thiamine deficiency impairs contractile function in
cardiomyocytes [98]. Though the heart failure is generally
attributed to decreased ThDP-dependent enzyme activities, our
results suggest that ThTP may also be involved in this
phenomenon. Indeed, during thiamine deficiency, both ThDP
and ThTP are reduced and our recent results show that ThTP
synthesis is probably mostly mitochondrial in the heart [28].
ThTP was rarely observed in gynecological specimen, but was
nearly always present in fetal tissue-derived samples. This might be
the consequence of a lower 25-kDa ThTPase activity in the latter.
ThTP levels are probably regulated by cytosolic 25-kDa
ThTPase, an enzyme mainly expressed in differentiated
cells
ThTP may accumulate in tissues devoid of this enzyme activity,
such as Electrophorus electricus electric organ [30], pig skeletal muscle
Figure 4. Western blots of human tissues and cultured cell lines
using a commercial mouse polyclonal antibody. The antibody
was raised against human recombinant 25-kDa hThTPase. The samples
were homogenized and centrifuged (20 0006g, 30 min). In the case of
the biological samples, 40 mg of cytosolic protein were loaded on the
gel; for hThTPase, the amount was 0.5 mg. The arrow indicates the
location of 25-kDa hThTPase. (Ex, ectocervix; En, endometrium; hT,
human recombinant ThTPase; L, human LN-18 glioblastoma cells; S,
human SK-N-BE neuroblastoma cells; U, uterus; Tr, trophoblast).
doi:10.1371/journal.pone.0013616.g004
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a higher ThTP content than rodent brain (Table 7), which has a
high ThTPase activity. The inverse relationship between ThTPase
activity and ThTP content also holds for human tissues (Tables 4
and 5): 25-kDa ThTPase activity is lower and ThTP content is
higher in fetal tissue and trophoblast than in uterus, for instance.
ThTPase activity appeared to correlate with the protein expression
as determined by Western blotting (Fig. 4). Strangely, in human
cell lines, ThTPase activity, as well as the ThTPase protein, were
undetectable. These results suggest that ThTPase expression is
linked to the degree of differentiation of the cells. Highly
differentiated and quiescent cells such as neurons [38] and, in
general, adult tissue in rodents [37] and humans (this study)
contain a higher ThTPase activity than non-differentiated fast-
growing cells. Though the ThTPase mRNA expression does not
correlate with enzyme activities [37], using a semi-quantitative
profiling of ThTPase mRNA on a human multiple tissue
expression array, we found a low expression in fetal tissue and
the highest expression in uterus, testis and prostate, with
intermediate expression in liver, skeletal muscle or brain [36].
An increase in 25-kDa ThTPase activity after birth was also
observed in rat brain and liver [99].
AThTP is a minor compound mainly present poorly
differentiated fast-growing cells
We show for the first time the existence of AThTP and, very
sporadically, of AThDP in human tissues. Interestingly, AThTP is
found mainly in fetal or fetus-derived tissues and also in cultured
cells but rarely in well-differentiated tissues. Moreover, its presence
is at least statistically linked to the presence of detectable amounts
of ThTP. It is indeed rarely seen in the absence of ThTP, both
biopsies and in cultured cells. This is in contrast to E. coli cells in
which both compounds to not accumulate together. In E. coli,
AThTP accumulates in response to carbon starvation or collapse
of the transmembrane proton gradient [39,40], but we have no
clue as to the regulation of AThTP levels in animal tissues.
Conclusions
In summary, the present data substantiate the view that
thiamine status is particularly low in humans compared to other
mammalian species (especially rodents). This justifies the proposal
that thiamine supplementation should be envisaged in many
pathological states, especially in elderly patients. An interesting
new finding is that ThTP is found in many human tissues at a
concentration higher than in other mammalian species, and this is
likely due to a lower expression of the specific 25-kDa ThTPase.
The possible physiological roles of ThTP and ThTPase are a
subject of active investigation in our laboratory. We show for the
first time the occurrence of adenylated thiamine derivatives in
human tissues. AThTP was found sporadically in many samples,
but very consistently in fetal and fetal-derived tissues and cultured
cells. It might thus play a role in rapidly dividing cells.
Materials and Methods
Materials
All solutions were prepared using milli-Q water (Millipore S.A./
N.V., Brussels, Belgium) and all the solvents used for chromatog-
raphy were of HPLC grade (Biosolve, Valkenswaard, The
Netherlands). Thiamine, ThMP and ThDP were from Sigma-
Aldrich NV/SA (Bornem, Belgium). ThTP and AThTP, which
are not commercially available, were synthesized as described
[42,100]. All other chemicals were from Merck (Darmstadt,
Germany) or from Sigma-Aldrich and of the highest purity
available.
Ethics statement
The experimental procedures were in accordance with the
Declaration of Helsinki and were approved by the ethical
committees of the Hospital of the University of Lie `ge and the
Citadelle Hospital (Lie `ge). All tissue donors provided written
informed consent.
All animal experiments were made in accordance with the
directives of the committee for animal care and use of the
University of Lie `ge and in accordance with the European
Communities Council Directive of November 24, 1986 (86/
609/EEC). The protocols were approved by the Committee on
the Ethics of Animal Experiments of the University of Lie `ge
(# 823 for rats and # 727 for quails). The animals were killed by
decapitation and all efforts were made to minimize suffering.
Cell culture
Mouse neuroblastoma cells (neuro-2a, ATCC nu CCL-131),
mouse myoblasts (C2C12, ATCC nu CRL-1772) and mouse
fibroblasts (3T3, ATCC nu CRL-1658) were grown at 37uCi na
humidified atmosphere of 95% air, 5% CO2, in 10 cm Petri dishes
(Greiner Bio-One N.V./S.A., Wemmel, Belgium) in 10 mL of
Dulbecco’s modified Eagle’s medium (Invitrogen Life Technolo-
gies, Carlsbad, CA, USA) supplemented with fetal bovine serum
(10%). Cells were subcultured to a fresh culture dish when growth
reached 70–90% confluence, i.e. every 2–3 days. Human
neuroblastoma cells (SK-N-BE, ATCC nu RL-2271), human
glioblastoma (LN-18, ATCC nu CRL-2610) and rat phaeochro-
mocytoma cells (PC-12, ATCC nu CRL-1721) were grown at
37uC in a humidified atmosphere of 95% air, 5% CO2 in 10 cm
Petri dishes in 8 mL of DMEM supplemented with 10% heat-
inactivated horse serum (Invitrogen) and 5% fetal bovine serum.
The medium was changed every 2 days of culture and cells were
subcultured to a fresh culture dish when growth reached 70–90%
of confluence.
Preparation of tissue extracts or cultured cells for the
determination of thiamine derivatives
Human biopsies were frozen either in liquid nitrogen or on dry
ice as rapidly as possible after removal and stored at 280uC until
use. Blood samples were analyzed immediately, without freezing.
Male Wistar rats (200 g) and adult quails (14 weeks old) were from
the institutional animal facility and killed by decapitation. Pig
brains were from the local slaughterhouse and immediately frozen
on dry ice.
Frozen tissues (approximately 10–50 mg) were homogenized in
10–50 volumes (0.5–1 mL) of trichloroacetic acid (TCA, 12%) in a
glass-glass Potter-Elvehjem homogenizer. In some cases, liver
samples were homogenized in a medium containing D-mannitol
225 mM), sucrose (75 mM), Hepes (7.5 mM), EDTA (0.5 mM),
BSA fatty acid free (0.1%, w/v), pH adjusted to 7.3 with KOH.
The homogenate was centrifuged (100 0006g, 60 min) to obtain
the cytosolic and the particulate fractions.
Whole semen was precipitated with 2 volumes of TCA (18%).
In some cases, fresh semen was centrifuged (5006 g, 10 min) to
obtain the seminal fluid that was also precipitated with 2 volumes
of TCA (18%). We used computer-assisted semen analysis
(AutoSperm, MedCalc Software bvba, Mariakerke, Belgium) for
the determination of sperm concentration and motility [101]. An
aliquot from a homogeneous, mixed semen sample was placed in
counting chamber at room temperature and recorded by a video
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criteria [102].
Venous blood samples (265 mL) were taken from healthy
volunteers using EDTA blood collection tubes. The blood was
treated with 2 volumes of TCA (18%). For the analysis of human
plasma, the blood was centrifuged (11006g, 15 min, 4uC) and the
supernatant treated with 0.2 volumes of 72% TCA.
Cultured cells were detached with trypsin, centrifuged (3506g,
3 min) and the pellet suspended in 500 mL of 72% TCA.
All the samples were centrifuged (50006 g, 5 min), and the
TCA was removed by diethyl ether extraction (361.5 mL). They
were stored frozen at 220uC until determination of thiamine
derivatives by HPLC.
Determination of thiamine derivatives by HPLC
Thiamine compounds were determined by HPLC as previ-
ously described after transformation into fluorescent thiochrome
derivatives [42,103]. Prior to analysis, an 80 ml aliquot was
oxidized with 50 ml of 4.3 mM potassium ferricyanide in 15%
NaOH and a 20-ml sample volume was injected into the
chromatographic system (System 522, Kontron Instruments,
Milan, Italy). The separation was performed at a flow rate of
0.5 ml/min on a PRP-1 column (Ø 4.16150 mm, Hamilton Co,
Reno, NV, USA) in 50 mM NaH2PO4 containing 25 mM tetra-
n-butylammonium hydrogen sulfate and 4% tetrahydrofuran and
adjusted to pH 9.5 with NaOH. Thiochrome derivatives were
quantified using a fluorometric spectrometer (LS-4, Perkin-
E l m e r ,S h e l t o n ,C T ,U S A ,o rS F M2 5 ,K o n t r o nI n s t r u m e n t s ) .
Proteins were determined in the pellets by the method of
Peterson [104] after solubilization in an initial volume of 1 N
NaOH.
In some cases, the presence of authentic ThTP was demon-
strated by hydrolysis with the specific recombinant mouse 25-kDa
ThTPase [35]. The extract (80 mL) was mixed with 15 mL of Bis-
Tris-Propane buffer (0.5 M, pH 8.9), 5 mL MgCl2 (0.1 M) and
2 mL of the purified recombinant mThTPase (diluted 1006)a t
37uC. After incubation (15 min, 37uC), the mixture was put on ice
and analyzed by HPLC. In control experiments, the enzyme was
replaced by 2 mLH 2O.
Preparation of tissue extracts for the determination of
25-kDa ThTPase activity and Western blots
Human tissues were homogenized in a glass-glass Potter-
Elvehjem homogenizer with 5 volumes of dilute Tris buffer
(5 mM Tris-HCl, 0.5 mM EDTA, pH 8.2) supplemented with
protease inhibitors (complete mini EDTA-free Protease Inhibitor
Cocktail Tablets, Roche Applied Science, Vilvoorde, Belgium).
Homogenates were centrifuged at 4uC for 30 min at 20 0006g.
The supernatant was used for the determination of ThTPase and
protein concentrations as well as for Western blots.
RT-PCR detection of 25-kDa ThTPase mRNA in human
and mouse cells
Total RNA was extracted from mouse and human cells using
RNA InstaPure System (Eurogentec, Belgium) according to the
manufacturer’s instruction. It was then transcribed in cDNA in
20 ml solution containing 5 mg of total RNA (Promega Benelux
b.v., Leiden, The Netherlands).
ThTPase-specific fragments were amplified using specific
forward primers (GCT GCA GGA AGT AGC TAG TT and
GCA GGA GGT GGC TAG TTT T) and reverse primers (AGC
TGT TCA CTT CTA GCA GG and AGA ACT GGC TGC
TTC TAG CA) for human and mouse mRNA sequences. The
sequence amplified by these primers ranged from nucleotides 342
to 643 and 345 to 645 on human and mouse coding sequence
respectively. The PCR reactions using these primers were
composed of 1 ml cDNA, 5 ml of each primer (100 mM) and
0.5 ml (2.5 U) Go Taq DNA polymerase in a final volume of 50 ml.
PCR cycling parameters consisted of 5 min at 95uC and 35 cycles
of 30 s at 94uC, 30 s at 55uC, and 30 s at 72uC, with a final step of
5 min at 72uC (T3000 Thermocycler, Biometra GmbH, Goettin-
gen, Germany). Amplified products were visualized with ethidium
bromide staining after electrophoresis on 1% agarose gel. The
sequence of PCR products was confirmed by nucleic acid
sequencing (GIGA, University of Lie `ge).
ThTPase activity measurements
Supernatant fractions from tissue or cell homogenates were
used for the determination of ThTPase activity [22]. The rate of
ThTP hydrolysis was measured in 50 mM Tris-HCl buffer,
pH 8.5 in the presence of 10 mM MgCl2 and 10 mMT h T Pi na
final volume of 100 ml. The reaction was stopped by addition of
0.5 mL of 12% TCA. The samples were centrifuged (50006g,
5 min) and extracted with diethyl ether. The disappearance of
ThTP and the production of ThDP were determined by HPLC
[103].
Western blotting
Soluble cytosolic fractions were separated by SDS-PAGE
electrophoresis using 0.75 mm thick 12% acrylamide gels. 40 mg
of proteins were loaded per well and electrophoresis was carried
out at room temperature for 1 h using 20 mA current per gel.
0.5 mg of purified human recombinant 25-kDa ThTPase was used
as reference [82]. Proteins were transferred to Hybond-P PVDF
Membrane (GE Healthcare Europe GmbH, 201831 Diegem,
Belgium) using wet transfer at 4uC for 2 h at 50 V. Membranes
were treated for 1 h with TBS-T (50 mM Tris-HCl, pH 7.6,
150 mM NaCl, 0.2% Tween 20, pH 7.4) containing 5% dry milk
and then incubated overnight at 4uC with mouse anti-ThTPA
poly- and monoclonal (clone 3F6) antibodies (Abnova GmbH,
69126 Heidelberg, Germany) diluted 1:3000 in TBS-T with 5%
dry milk. After incubation, the membranes were washed 3 times
for 5 min in TBS-T and incubated at room temperature for 1 h
with peroxidase-conjugated AffiniPure F(ab’)2 fragment rat anti-
mouse secondary antibodies diluted 1:3000 in TBS-T with 5% dry
milk. Then the membranes were washed three times in TBS-T
and the protein bands were revealed by incubation for 60 s at
room temperature using SuperSignal West Pico Chemilumines-
cent Substrate (Thermo Scientific, Fisher Scientific, Tournai,
Belgium).
Statistical analyses
ANOVA and linear regression analysis were made using Prism
4 or InStat 3 for Macintosh (GraphPad Software). In some cases
post hoc comparisons were made using Tukey’s test. Coefficients
of variation (Cv) were calculated as the ratios of the standard
deviation (SD) to the mean, Cv = SD/Mean. Contingency tables
were analyzed using Fisher’s exact test.
Supporting Information
File S1 Western blots of human tissue and cultured cell lines
using a commercial mouse monoclonal antibody.
Found at: doi:10.1371/journal.pone.0013616.s001 (0.28 MB
DOC)
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